Elite in Chagas Disease

Alejandro G. Schijman

Instituto De Investigaciones En Ingeniería Genética Y Biología Molecular Dr. Héctor N Torres, Consejo Nacional De Investigaciones Científicas Y Técnicas, 
Torres, B, AR 
Elite in Chagas Disease
Instituto De Investigaciones En Ingeniería Genética Y Biología Molecular Dr. Héctor N Torres, Consejo Nacional De Investigaciones Científicas Y Técnicas, 
Torres, B, AR 
OverviewLocationsClinical Research

Overview

Alejandro Schijman practices in Torres, Argentina. Mr. Schijman is rated as an Elite expert by MediFind in the treatment of Chagas Disease. His top areas of expertise are Chagas Disease, Chronic Familial Neutropenia, Pediatric Myocarditis, and Sepsis.

His clinical research consists of co-authoring 100 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 92 articles and participated in 1 clinical trial in the study of Chagas Disease.

Gender
Male

Locations

Instituto De Investigaciones En Ingeniería Genética Y Biología Molecular Dr. Héctor N Torres, Consejo Nacional De Investigaciones Científicas Y Técnicas, Torres, B, Argentina
Other Locations
B, Argentina
Vuelta De Obligado, B, Argentina
Buenos Aires, C, Argentina

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age: A Non-inferiority Randomized Controlled Trial
Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age: A Non-inferiority Randomized Controlled Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 21, 2025
Intervention Type: Drug
Study Drug: Benznidazole
Study Phase: Phase 3

100 Total Publications

New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial.
New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial.
Journal: BMJ open
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schijman's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile